ResearcherJena University HospitalNo recent work listed

Mourad Sanhaji

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8202-0694; OpenAlex author ID A5060572157. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 1 paper

Papers 1

The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide … Co-author DOI 10.1016/j.nano.2018.12.019 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Robert Ludwig · 1 shared paper, 2019 · strength 0.08
- Paper The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carry… DOI 10.1016/j.nano.2018.12.019 ↗
Álvaro Somoza · 1 shared paper, 2019 · strength 0.08
- Paper The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carry… DOI 10.1016/j.nano.2018.12.019 ↗
Adriele Prina‐Mello · 1 shared paper, 2019 · strength 0.08
- Paper The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carry… DOI 10.1016/j.nano.2018.12.019 ↗
Aitziber L. Cortajarena · 1 shared paper, 2019 · strength 0.08
- Paper The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carry… DOI 10.1016/j.nano.2018.12.019 ↗
Ingrid Hilger · 1 shared paper, 2019 · strength 0.08
- Paper The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carry… DOI 10.1016/j.nano.2018.12.019 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.